Ameritas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Buy |
+302
| New | +$134K | 0.01% | 871 |
|
|
2024
Q3 | – | Sell |
-1,260
| Closed | -$591K | – | 945 |
|
|
2024
Q2 | $591K | Buy |
+1,260
| New | +$591K | 0.02% | 541 |
|
|
2023
Q4 | – | Sell |
-1,539
| Closed | -$564K | – | 848 |
|
|
2023
Q3 | $564K | Buy |
+1,539
| New | +$564K | 0.03% | 474 |
|
|
2023
Q2 | – | Sell |
-335
| Closed | -$107K | – | 2477 |
|
|
2023
Q1 | $107K | Buy |
+335
| New | +$107K | 0.01% | 979 |
|